157 related articles for article (PubMed ID: 35172317)
1. Long-Term Time Series Forecasting and Updates on Survival Analysis of Glioblastoma Multiforme: A 1975-2018 Population-Based Study.
Alexopoulos G; Zhang J; Karampelas I; Patel M; Kemp J; Coppens J; Mattei TA; Mercier P
Neuroepidemiology; 2022; 56(2):75-89. PubMed ID: 35172317
[TBL] [Abstract][Full Text] [Related]
2. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.
Thumma SR; Fairbanks RK; Lamoreaux WT; Mackay AR; Demakas JJ; Cooke BS; Elaimy AL; Hanson PW; Lee CM
World J Surg Oncol; 2012 May; 10():75. PubMed ID: 22553975
[TBL] [Abstract][Full Text] [Related]
4. Clinical features associated with the efficacy of chemotherapy in patients with glioblastoma (GBM): a surveillance, epidemiology, and end results (SEER) analysis.
Wen J; Chen W; Zhu Y; Zhang P
BMC Cancer; 2021 Jan; 21(1):81. PubMed ID: 33468109
[TBL] [Abstract][Full Text] [Related]
5. Impact of gender on the survival of patients with glioblastoma.
Tian M; Ma W; Chen Y; Yu Y; Zhu D; Shi J; Zhang Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305382
[No Abstract] [Full Text] [Related]
6. Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001.
Deorah S; Lynch CF; Sibenaller ZA; Ryken TC
Neurosurg Focus; 2006 Apr; 20(4):E1. PubMed ID: 16709014
[TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
8. Effect of marital status on survival in glioblastoma multiforme by demographics, education, economic factors, and insurance status.
Xie JC; Yang S; Liu XY; Zhao YX
Cancer Med; 2018 Aug; 7(8):3722-3742. PubMed ID: 30009575
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic and molecular prognostic review of glioblastoma.
Thakkar JP; Dolecek TA; Horbinski C; Ostrom QT; Lightner DD; Barnholtz-Sloan JS; Villano JL
Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1985-96. PubMed ID: 25053711
[TBL] [Abstract][Full Text] [Related]
10. Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.
Al-Husseini MJ; Saad AM; El-Shewy KM; Nissan NE; Gad MM; Alzuabi MA; Samir Alfaar A
Int J Neurosci; 2019 May; 129(5):447-454. PubMed ID: 30366515
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
[TBL] [Abstract][Full Text] [Related]
12. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
Kozak KR; Moody JS
Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
[TBL] [Abstract][Full Text] [Related]
13. Outcome and prognostic factors in adult cerebellar glioblastoma.
Babu R; Sharma R; Karikari IO; Owens TR; Friedman AH; Adamson C
J Clin Neurosci; 2013 Aug; 20(8):1117-21. PubMed ID: 23706183
[TBL] [Abstract][Full Text] [Related]
14. Long-term glioblastoma multiforme survivors: a population-based study.
Scott JN; Rewcastle NB; Brasher PM; Fulton D; Hagen NA; MacKinnon JA; Sutherland G; Cairncross JG; Forsyth P
Can J Neurol Sci; 1998 Aug; 25(3):197-201. PubMed ID: 9706720
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
[TBL] [Abstract][Full Text] [Related]
16. Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.
Darefsky AS; King JT; Dubrow R
Cancer; 2012 Apr; 118(8):2163-72. PubMed ID: 21882183
[TBL] [Abstract][Full Text] [Related]
17. Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study.
Rong X; Yang W; Garzon-Muvdi T; Caplan JM; Hui X; Lim M; Huang J
Cancer; 2016 Oct; 122(20):3157-3165. PubMed ID: 27500668
[TBL] [Abstract][Full Text] [Related]
18. Improving prognosis of glioblastoma in the 21st century: who has benefited most?
Lawrence YR; Mishra MV; Werner-Wasik M; Andrews DW; Showalter TN; Glass J; Shen X; Symon Z; Dicker AP
Cancer; 2012 Sep; 118(17):4228-34. PubMed ID: 22180310
[TBL] [Abstract][Full Text] [Related]
19. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
[TBL] [Abstract][Full Text] [Related]
20. Risk of subsequent cancer among pediatric, adult and elderly patients following a primary diagnosis of glioblastoma multiforme: a population-based study of the SEER database.
Li X; Li Y; Cao Y; Li P; Liang B; Sun J; Feng E
Int J Neurosci; 2017 Nov; 127(11):1005-1011. PubMed ID: 28288541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
